Found 10 results
Author Title [ Type(Asc)] Year
Filters: Author is Hu, Z  [Clear All Filters]
Journal Article
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 311 St, “Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial”, Lancet, vol. 384, pp. 2046-2052, 2014.
H. Kibuuka, Berkowitz, N., Millard, M., Enama, M., Tindikahwa, A., Sekiziyivu, A., Costner, P., Sitar, S., Glover, D., Hu, Z., Joshi, G., Stanley, D., Kunchai, M., Eller, L., Bailer, R., Koup, R., Nabel, G., ,, Robb, M., Ledgerwood, J., and Team, T. R. V. 247 Stu, “Safety and Immunogenicity of Ebola Virus and Marburg Virus Glycoprotein DNA Vaccines Assessed Separately and Concomitantly in Healthy Ugandan Adults: A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Clinical Trial”, Lancet, vol. 385, pp. 1545-1554, 2015.
U. Sarwar, Costner, P., Enama, M., Berkowitz, N., Hu, Z., Hendel, C., Sitar, S., Plummer, S., Mulangu, S., Bailer, R., Koup, R., Mascola, J., Nabel, G., Sullivan, N., Graham, B., Ledgerwood, J. E., and Team, T. V. R. C. 206 St, “Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial”, J Infect Dis, vol. 211, pp. 549-557, 2015.
J. E. Ledgerwood, Costner, P., Desai, N., Holman, L., Enama, M. E., Yamshchikov, G., Mulangu, S., Hu, Z., Andrews, C. A., Sheets, R. A., Koup, R. A., Roederer, M., Bailer, R., Mascola, J. R., Pau, M. G., Sullivan, N. J., Goudsmit, J., Nabel, G. J., and Graham, B. S., “A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.”, Vaccine, vol. 29, no. 2, pp. 304-13, 2010.
J. E. Ledgerwood, Costner, P., Desai, N., Holman, L., Enama, M. E., Yamshchikov, G., Mulangu, S., Hu, Z., Andrews, C. A., Sheets, R. A., Koup, R. A., Roederer, M., Bailer, R., ,, Pau, M. G., Sullivan, N. J., Goudsmit, J., Nabel, G. J., Graham, B. S., and Team, T. V. R. C. 205 St, “A Replication Defective Recombinant Ad5 Vaccine Expressing Ebola Virus GP is Safe and Immunogenic in Healthy Adults”, Vaccine, vol. 29, pp. 304-313, 2010.
J. E. Ledgerwood, Zephir, K., Hu, Z., Wei, C. J., Chang, L., Enama, M. E., Hendel, C. S., Sitar, S., Bailer, R. T., Koup, R. A., ,, Nabel, G. J., Graham, B. S., and Team, T. V. R. C. 310 St, “Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect”, J Infect Dis, vol. 208, pp. 418-422, 2013.
M. Crank, Gordon, I., Yamshchikov, G., Sitar, S., Hu, Z., Enama, M., Holman, L., Bailer, R., Pearce, M., Koup, R., Mascola, J., Nabel, G., Tumpey, T., Schwartz, R., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 308 St, “Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults”, PLoS One, vol. 10, p. e0123969, 2015.
J. E. Ledgerwood, Wei, C. J., Hu, Z., Gordon, I. J., Enama, M. E., Hendel, C. S., McTamney, P. M., Pearce, M. B., Yassine, H. M., Boyington, J. C., Bailer, R., Tumpey, T. M., Koup, R. A., ,, Nabel, G. J., Graham, B. S., and Team, T. V. R. C. 306 St, “DNA Priming and Influenza Vaccine Immunogenicity: Two Phase 1 Open Label Randomised Clinical Trials”, Lancet Infect Dis, vol. 11, pp. 916-924, 2011.
J. Ledgerwood, DeZure, A., Stanley, D., Novik, L., Enama, M., Berkowitz, N., Hu, Z., Joshi, G., Ploquin, A., Sitar, S., Gordon, I., Plummer, S., Holman, L., ,, Mascola, J., Koup, R., Sullivan, N., Graham, B., and Team, T. V. R. C. 207 St, “Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report”, N Engl J Med, 2014.
Conference Paper
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W., Pasquini, M., MacMillan, M., Wingard, J., Waller, E., Grupp, S., McCarthy, P., Wu, J., Hu, Z., Carter, S., Horowitz, M. M., and Antin, J. H., “Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.